First author [ref.] | Treatment arm | Patients n | Objective response % | p-value | Median survival months | p-value |
Garassino [6] | Erlotinib | 112 | 3 | 0.001 | 5.4 | 0.05 |
Docetaxel | 110 | 15.5 | 8.2 | |||
Zhou [7] | Gefitinib | 81 | 12.3 | ns | 9.6 | 0.077 |
Pemetrexed | 76 | 14.5 | 12.4 |
ns: nonsignificant.